Surmodics Investor Relations Material
Latest events
Q2 2024
Surmodics
Q2 2025
30 Apr, 2025
Q1 2025
30 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Surmodics Inc
Access all reports
Surmodics Inc. is a provider of medical device and in vitro diagnostic technologies. The company develops surface modification coatings, drug delivery technologies, and diagnostic components. Its products are used by medical device manufacturers and diagnostic test developers, particularly in cardiovascular and peripheral vascular applications. Surmodics also offers contract research and development services. The company is headquartered in Eden Prairie, Minnesota, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
SRDX
Country
🇺🇸 United States